William D Kerns DVM, MS, DACVP
Dr. Kerns is an entrepreneur and co-founder of Synchroneuron Inc.
medical training in Veterinary Medicine and graduate work in Pharmacology and Pathology at The Ohio State University
graduate program, he
studied molecular mechanisms of cardiac hypertrophy.
In 1980, he
successfully completed examination by the American College of Veterinary Pathologists
Dr. Kerns has 30 years of experience in pharmaceutical research and development, having held senior executive positions in preclinical development at SmithKlineFrench, SmithKlineBeecham, and Eisai during his pharmaceutical career.
is recognized as an expert in drug development and safety assessment and an expert on mechanisms of drug-induced cardiovascular toxicity.
has authored or co-authored over 100 articles and has co-edited a book on cardiovascular toxicology.
has been actively involved in the SOT, STP and ACVP
has co-chaired an FDA
expert committee on biomarkers of drug-induced vascular injury. .
has participated in the successful management and activation of over 200 INDs and 15 NDAs during his
oversees the submission of 3-4 INDs each year across multiple divisions at FDA.
Dr. Kerns is also a co-founder and the CEO of Accellient Partners, LLC, a drug development consultancy in Waltham, MA.